Placenta-associated complications as risk factors for induction of preterm labor: perinatal aspects

Remneva O.V.; Kolyado O.V.; Molchanova I.V.; Tanysheva G.A.; Nikolaeva A.S.; Dyusupov A.A.

doi:https://doi.org/10.17116/rosakush20262601142

Remneva O.V.

Altai State Medical University, Barnaul, Russia;
Altai Regional Clinical Perinatal Center, Barnaul, Russia

ORCID: 0000-0002-5984-1109

Kolyado O.V.

Altai State Medical University, Barnaul, Russia;
Altai Regional Clinical Perinatal Center, Barnaul, Russia

ORCID: 0000-0002-5812-4925

Molchanova I.V.

Altai State Medical University, Barnaul, Russia;
Altai Regional Clinical Perinatal Center, Barnaul, Russia

ORCID: 0000-0002-0741-8974

Tanysheva G.A.

Semey Medical University, Semey, Republic of Kazakhstan

ORCID: 0000-0001-9531-5950

Nikolaeva A.S.

Semey Medical University, Semey, Republic of Kazakhstan

ORCID: 0000-0002-2642-5141

Dyusupov A.A.

Semey Medical University, Semey, Republic of Kazakhstan

ORCID: 0000-0003-0875-1020

Placenta-associated complications as risk factors for induction of preterm labor: perinatal aspects

Authors:

Remneva O.V., Kolyado O.V., Molchanova I.V., Tanysheva G.A., Nikolaeva A.S., Dyusupov A.A.

More about the authors

Journal: Russian Bulletin of Obstetrician-Gynecologist. 2026;26(1): 42‑50

DOI: 10.17116/rosakush20262601142

Read: 404 times

Contact the author

Table of contents

To cite this article:

Remneva OV, Kolyado OV, Molchanova IV, Tanysheva GA, Nikolaeva AS, Dyusupov AA. Placenta-associated complications as risk factors for induction of preterm labor: perinatal aspects. Russian Bulletin of Obstetrician-Gynecologist. 2026;26(1):42‑50. (In Russ.)
https://doi.org/10.17116/rosakush20262601142

Подписка 2026 Российский вестник акушера-гинеколога (Russian Bulletin of Obstetrician-Gynecologist)

Использование инфографики авторами научных работ

OBJECTIVE

To determine risk factors for induction of preterm labor and the severity of oxidative stress in fetuses undergoing abdominal delivery due to placenta-associated complications.

MATERIAL AND METHODS

A total of 152 pregnant women were examined and divided into two groups. The study group included 102 patients with abdominal preterm labor induced by placenta-associated complications. The comparison group consisted of 50 pregnant women who had a planned term cesarean section for obstetric indications with satisfactory fetal condition. The practical significance of malondialdehyde, matrix metalloproteinases of the 1^st and 9^th families, and their tissue inhibitor (TIMP-1) was studied as predictors of cerebral disorders in preterm fetuses/newborns during induction of preterm labor due to life-threatening conditions for the mother and fetus.

RESULTS

The following clinical and anamnestic risk factors were established for induction of preterm labor in pregnant women with developed placenta-associated complications: hypertensive disorders (odds ratio, OR, 13.9); chronic pelvic inflammatory diseases; genital infections (OR, 4.06); urinary tract infections (OR, 3.3); and a history of two or more artificial abortions (OR, 3.2). Malondialdehyde, matrix metalloproteinases of families 1 and 9, and their tissue inhibitor, TIMP-1, were identified in biological fluids as laboratory predictors of the severity of cerebral disorders in premature fetuses/newborns.

CONCLUSION

Predicting the severity of cerebral disorders in fetuses during preterm abdominal delivery by determining the concentration of malondialdehyde in amniotic fluid, the activity of matrix metalloproteinases of families 1 and 9, and their tissue inhibitor, as well as their early detection in cord blood, allows for the initiation of rehabilitation measures immediately after birth. Identifying preconception clinical and anamnestic risk factors for induced preterm labor due to placenta-associated complications allows for a differentiated approach to planning subsequent pregnancies.

Keywords:

induced preterm labor

placenta-associated complications

matrix metalloproteinase

oxidative stress

malondialdehyde

Authors:

Remneva O.V.

Altai State Medical University, Barnaul, Russia;
Altai Regional Clinical Perinatal Center, Barnaul, Russia

ORCID: 0000-0002-5984-1109

Kolyado O.V.

Altai State Medical University, Barnaul, Russia;
Altai Regional Clinical Perinatal Center, Barnaul, Russia

ORCID: 0000-0002-5812-4925

Molchanova I.V.

Altai State Medical University, Barnaul, Russia;
Altai Regional Clinical Perinatal Center, Barnaul, Russia

ORCID: 0000-0002-0741-8974

Tanysheva G.A.

Semey Medical University, Semey, Republic of Kazakhstan

ORCID: 0000-0001-9531-5950

Nikolaeva A.S.

Semey Medical University, Semey, Republic of Kazakhstan

ORCID: 0000-0002-2642-5141

Dyusupov A.A.

Semey Medical University, Semey, Republic of Kazakhstan

ORCID: 0000-0003-0875-1020

Received:

06.04.2025

Accepted:

06.05.2025

Close metadata

References:

Herraiz I, Simón E, Gómez-Arriaga PI, Martínez-Moratalla JM, García-Burguillo A, Jiménez EAL, Galindo A. Angiogenesis-related biomarkers (sFlt-1/PLGF) in the prediction and diagnosis of placental dysfunction: An Approach for Clinical Integration. Int J Mol Sci. 2015;13:16:8:19009-19026. https://doi.org/10.3390/ijms160819009
Revina DB, Balatskii AV, Larina EB, Mamedov NN, Samokhodskaya LM, Panina OB. Placental-related disorders of pregnancy: the influence of rs4065 polymorphism of the urokinase gene. Voprosy ginekologii akusherstva i perinatologii. 2021;20:1:5-10. (In Russ.). https://doi.org/10.20953/1726-1678-2021-1-5-10
Timokhina EV, Strizhakov AN, Zafiridi NV, Fedyunina IA, Aslanov AG. Early fetal growth restriction: a new approach to guide the choice of management strategy. Akusherstvo i ginekologiya. 2021;9:42-49. (In Russ.). https://doi.org/10.18565/aig.2021.9.42-49
Minaeva EA, Shmakov RG. Risk factors and prevention of placenta-associated diseases. Ginekologiya. 2021;23:3:236-240. (In Russ.). https://doi.org/10.26442/20795696.2021.3.200960
Strizhakov AN, Tezikov YuV, Lipatov IS, Pechkurov DV. Association between placental insufficiency and manifestations of preeclampsia. Akusherstvo, ginekologiya i reproduktsiya. 2018;12:3: 17-28. (In Russ.). https://doi.org/10.17749/2313-7347.2018.12.3.017-028
Hoffman MK. The great obstetrical syndromes and the placenta. BJOG. 2023;130:3:8-15. https://doi.org/10.1111/1471-0528.17613
Sidorkina AG, Mudrov VA. Modern ideas about the pathogenesis of chronic placental insufficiency. Russian Bulletin of Obstetrician-Gynecologist. 2024;24:1:12-18. (In Russ.). https://doi.org/10.17116/rosakush20242401112
Shalina RI, Spiridonov DS, Latyshkevich OA, Vykhristyuk YuV, Kunyakh ZhYu, Andreev AI. Spontaneous and induced extremely preterm birth: outcomes for children. Voprosy ginekologii akusherstva i perinatologii. 2018;17:2:54-61. (In Russ.). https://doi.org/10.20953/1726-1678-2018-2-54-61
Nosovskii AM, Pikhlak AE, Logachev VA, Chursinova II, Mut’eva NA. Small — data statistics analysis in medical studies. Rossiiskii meditsinskii zhurnal. 2013;6:57-60. (In Russ.).
Remneva OV, Korenovskii YuV, Khovalyg NM, Kolyado OV. Induced preterm birth: evaluation of oxidative status, matrix metalloproteinases and their tissue inhibitors in amniotic fluid. Nauchnye rezul’taty biomeditsinskikh issledovanii. 2021;7:1:86-95. (In Russ.). https://doi.org/10.18413/2658-6533-2020-7-1-0-9
Kholodova IN, Zaidenvarg GE, Goryainova AN. Children after Caesarean section: how to improve their adaptation and reduce the risk of pathological conditions. Meditsinskii sovet. 2019;11:16-22. (In Russ.). https://doi.org/10.21518/2079-701X-2019-11-16-22
Cerdeira AS, Agrawal S, Staff AC, Redman CW, Vatish M. Angiogenic factors: potential to change clinical practice in pre-eclampsia? BJOG. 2018;125:11:1389-1395. https://doi.org/10.1111/1471-0528.15042
Belousova VS, Strizhakov AN, Svitich OA, Timokhina EV, Kukina PI, Bogomazova IM, Pitskhelauri EG. Preterm birth: causes, pathogenesis, and management. Akusherstvo i ginekologiya. 2020;2:82-87. (In Russ.). https://doi.org/10.18565/aig.2020.2.82-87
Beglov DE, Artymuk NV, Novikova OV, Marochko KV, Parfenova YaA. Risk factors for extremely preterm birth. Fundamental’naya i klinicheskaya meditsina. 2022;7:4:8-17. (In Russ.). https://doi.org/10.23946/2500-0764-2022-7-4-8-17
Remneva OV, Fadeeva NI, Yavorskaya SD, Korenovskii YuV, Kolyado OV. Early markers of perinatal cerebral ischemia in newborns. Giornale Italiano di ostetricia ginecologia. 2019;39:2:58-61.
Malinina EI, Chernysheva TV, Rychkova OA, Mazalova MV, Yuzhakova NYu. The concentration of matrix metalloproneinase — 2, 9 in newborns with perinatal hypoxia [electronic resource]. Sovremennye problemy nauki i obrazovaniya. 2019; 2. (In Russ.). Available from: https://science-education.ru/ru/article/view?id=28636
Timokhina E, Strizhakov A, Ibragimova S, Gitel E, Ignatko I, Belousova V, Zafiridi N. Matrix metalloproteinases MMP-2 and MMP-9 occupy a new role in sever preeclampsia. J Pregn. 2020; 16:8369645. https://doi.org/10.1155/2020/8369645
Toghi CJ, Martins LZ, Pacheco LL, Caetano ESP, Mattos BR, Rizzi E, Dias-Junior CA. Pravastatin prevents increases in activity of metalloproteinase-2 and oxidative stress, and enhances endothelium-derived nitric oxide-dependent vasodilation in gestational hypertension. Antioxidants (Basel). 2023;16:12:4:939. https://doi.org/10.3390/antiox12040939
Feng H, Wang L, Zhang M, Zhang Z, Guo W, Wang X. Ratio of matrix metalloproteinase-2 to -9 is a more accurate predictive biomarker in women with suspected pre-eclampsia. Bioscie Reports. 2017;15:37:2. BSR20160508. https://doi.org/10.1042/BSR20160508
Dolgova NS, Yavorskaya SD, Mikhalev EV, Korenovskii YuV, suzopov EV, Zharikova GV, Dmitrienko KV. Predicting cerebral disorders in low birth weight newborns by mathematical modeling. Byulleten’ meditsinskoi nauki. 2022;4:50-57. (In Russ.). https://doi.org/10.31684/25418475-2022-4-50
Musco H, Beecher K, Chand KK, Boyd RN, Colditz PB, Wixey JA. The search for blood biomarkers that indicate risk of adverse neurodevelopmental outcomes in fetal growth restriction. Frontiers in Pediatrics. 2024;12:1396102. https://doi.org/10.3389/fped.2024.1396102